《大行報告》大華繼顯降理想汽車(02015.HK)評級至「沽售」 目標價下調至100元
大華繼顯發表報告指,理想汽車(02015.HK)的盈利表現面對逆風,在增程式電動車(EREV)的壟斷地位受到新競爭者的挑戰。今年以來,銷售趨勢開始轉弱,主要受累於市場放緩及競爭加劇,其產品已減價8%至10%,相信會進一步減價,將其2023至2025年三年期間的純利預測,分別下調12%、35%及55%,目標價由190元大削至100元,評級由「買入」降至「沽售」。
因應理想的銷售疲弱及市場競爭,該行將今明兩年的交付量預測,分別下調14%及33%,至50萬輛及65萬輛,公司預期今年交付80萬量的目標,相信難以達成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.